About Our Team
At Next Interactions, Inc., we apply the unique expertise of our team and our class-leading platform technologies to your biotech research and development problems.
Our team consists of scientists and entrepreneurs with extensive experience in protein interaction technologies, cell signaling and systems biology. We use our platform technology and expertise to decipher more complete and accurate protein-protein interactomes to accelerate your research and product development.
We have helped our clients with a variety of complex, high impact, difficult projects including the screening for novel tumor suppressor targets, PPIs in hearing disorders, interaction mappings for novel isoforms, plant interaction networks, among other state-of-the-art projects.
Our Team
Bernhard Suter
CEO and Co-Founder
I use my expertise in systems biology, yeast genetics and assay development to build perfect solutions for interaction screens. Prior to Next, I held academic positions at the UC Berkeley, the University of Toronto and in Germany
Evelin Szakal
CFO and VP of Business Development
My backgound is in economy, medical microbiology and quality in business management, with 25 years of experience. At Next Interactions I oversee the finances, business development, marketing & sales and general operations. Prior to Next I was involved in vaccine research, both in discovery phase and in clinical trials. I hold a degree in economics, a Ph.D. in medical microbiology from Europe and completed my postdoc at UCSF studying protein complexes.
Ann Holtz-Morris
Senior Scientist
I joined Next Interactions to optimize the Next Generation Sequencing based yeast two-hybrid methods. Experienced in both NGS and Y2H technology, I am interested in systems biology and pathway analysis. I also bring Galaxy based bioinformatics analysis skills. I enjoy equally my computer and laboratory work.
Rich Yu
Scientific advisor
As a biotech entrepreneur, former venture capital partner and biotech incubator manager, and scientist with experience in protein engineering and systems and synthetic biology, I contribute advise to technical development, company growth, and operations management.
Gustavo Pesce
Scientific advisor
I advise on the company’s development of next-gen Protein Protein Interaction assays based on the NGS-Y2H technology.
Andrew Mendelsohn
Advisor & Co-founder
I bring 30 years of expertise in molecular, cell and synthetic biology as a biotechnology researcher and serial entrepreneur. I also serve as the Director of Molecular Biology at a Silicon Valley biotechnology incubator and Director of Research at the Regenerative Sciences Institute.
Consult our Protein Interaction Screening Experts.
Contact Next Interactions for advice from our scientists about the best approach for elucidating the protein interactions you need to understand for your research. We can advise you on methods such as the NGS-yeast two-hybrid system, yeast two-hybrid system, how to compliment interactome coverage by mass spectrometry, and more.